IL10 and infection: One caveat is that the two genetically modified mouse models we used (uMT- and p110δE1020K-B mice) differ from controls not only in their number of IL10-producing tissue-resident B cells but also, for example, in their B-cell signaling, selection and antibody repertoire, which may modulate infection susceptibility46,51.